According to Reuters, Global Blood Therapeutics (GBT) approached by Novo Nordisk (NVO)
Danish drugmaker Novo Nordisk (NVO) has approached Global Blood Therapeutics (GBT), a U.S. biotechnology company focused on serious blood disorders, to discuss a potential acquisition,
Read More